Loading provider…
Loading provider…
Hematology & Oncology Physician in West Hollywood, CA
NPI: 1649473414Primary Practice Location
CEDARS-SINAI MEDICAL CENTER
8700 Beverly Blvd, Los Angeles, CA
Primary Employer
Cedars-Sinai Medical Center
cedars-sinai.org
HQ Phone
Get MD, MPH Andrew's Phone Numberphone_androidMobile
Get MD, MPH Andrew's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
CA State Medical License
2004 - 2026

American Board of Internal Medicine
Hematology

American Board of Internal Medicine
Medical Oncology
Tulane School of Medicine
medicine.tulane.edu
Medical School
Until 2003
University of Southern California/LAC+USC Medical Center
Fellowship • Hematology
2009 - 2010
Fellowship • Medical Oncology
2007 - 2009
University of Southern California/Los Angeles General Medical Center (USC/LA General)
Residency • Internal Medicine
2003 - 2006
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 207 | 817 |
| 2 | 99205New patient office or other outpatient visit, typically 60 minutes | 59 | 59 |
| 3 | 99232Subsequent hospital inpatient care, typically 25 minutes per day | 55 | 142 |
| 4 | 99215Established patient office or other outpatient, visit typically 40 minutes | 44 | 52 |
| 5 | 99222Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 15 | 15 |
Gender disparities in hepatocellular cancer survival.
Methylated SEPTIN9 plasma test for colorectal cancer detection may be applicable to Lynch syndrome.
Authors: Matthew Kalady, James Church, Sigurdis Haraldsdottir, Stephen Lanspa
Publication Date: 2019-03-11
Authors: Simon Lo, Stephen Pandol, Nicholas Nissen, Jun Gong
Journal: J Cachexia Sarcopenia Muscle
Publication Date: 2021-10-05
Lead Sponsor: Jun Gong, MD
Collaborators: Emmaus Medical, Inc.
Intervention / Treatment: DRUG: Gemcitabine, DRUG: Nab-paclitaxel, DRUG: L-glutamine
Lead Sponsor: ECOG-ACRIN Cancer Research Group
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: DRUG: Carboplatin, DRUG: Temozolomide, OTHER: Laboratory Biomarker Analysis, DRUG: Cisplatin, DRUG: Capecitabine, DRUG: Etoposide
Lead Sponsor: Memorial Sloan Kettering Cancer Center
Collaborators: Cedars-Sinai Medical Center, AstraZeneca
Intervention / Treatment: DRUG: Durvalumab, RADIATION: Stereotactic Ablative Body Radiotherapy (SABR)